So even if Google makes tweaks to the operation of Google Shopping in the short term, i.e. to avoid the risk of additional sanctions for non-compliance, years of uncertainty are being added to an antitrust investigation that has already clocked up more than six years of probes by EU regulators.
Additional reasons for non-compliance were lack of knowledge and poor quality of care at government hospitals.
Direct observations according to the 'My five moments for hand hygiene' approach still provide important additional information on non-compliance and quality of hand hygiene.
For a psychiatrist it is difficult to accurately estimate the additional risk of non-compliance after generic substitution for a particular patient.
Given these figures and the additional comments that non-compliance mainly occurred in non-ventilated, non-sedated patients, it is unlikely that these incidental failures to apply medication affected the effectiveness of the interventions.
As reported by Fleischhacker et al., there are several factors influencing compliance, therefore also affecting the additional risk of non-compliance after generic substitution.[ 8] Careful consideration of these factors may help a psychiatrist in assessing the likelihood that a particular patient may end up being non-compliant after generic substitution.
See articleOuch!The European Commission fined Microsoft an additional euro899m ($1.35 billion) for non-compliance with an antitrust decision handed down in 2004, bringing the total penalty in the case so far to euro1.68 billion.
Non-compliance involved additional combing or other unauthorised treatments (2 receiving lotion and 2 wet-combing) and one participant on wet-combing shaved his head.
Determinants of non-compliance with additional HZ vaccination were: perceived lack of recommendation by the GP, unwillingness to comply with the doctor's advice, perception of low risk of contracting HZ, perception of short pain duration of HZ and the opinion that vaccinations weaken one's natural defenses [ 8].
Out of the total number of 85 patients, 75 commenced on chemotherapy and were available for response evaluation (the reason for non-compliance from the additional 10 patients is shown in Table S1).
Clinicians forwarded additional blood samples for metabolite monitoring if non-compliance with oral mercaptopurine was suspected.
